medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 3

<< Back Next >>

Med Int Mex 2022; 38 (3)

Indication and adherence to venous thromboprophylaxis in a hospital of Cartagena, Colombia

Bornacelly A, Moreno-Pallares ED

Language: Spanish
References: 27
Page: 514-525
PDF size: 228.86 Kb.


ABSTRACT

Objective: To describe the indication and adherence to thromboprophylaxis in the Internal Medicine service of a reference Hospital in Cartagena, Colombia.
Materials and Methods: Non-experimental, observational, descriptive, crosssectional study with a two-dimensional approach in which clinical records of patients hospitalized in internal medicine were analyzed and medical personnel belonging to the internal medicine service were surveyed to explore their knowledge of the ACCP- 9.
Results: Two hundred seventy-three patients and forty physicians were included. The global adherence to thromboprophylaxis was 76.2%, the pharmacological was the most prescribed, with adequate doses and duration in 95% and 97% of the cases, respectively; with an underuse of 15.4%. A 30% of the physicians recorded the Padua scale in their medical records and 90% of the medical personnel had adequate knowledge of the thromboprophylaxis guidelines.
Conclusions: It is necessary to increase education and knowledge of thromboprophylaxis protocols in medical personnel.


REFERENCES

  1. Dennis RJ, Roa JH, Villadiego J, Mendez F, Vieda E, RestrepoH. [Venous thromboembolism prophylaxis in Colombiansurgical and medical patients: results for Colombia of theENDORSE study]. Biomedica 2011; 31 (2): 200-8. https://doi.org/10.7705/biomedica.v31i2.304

  2. Moser KM, LeMoine JR. Is embolic risk conditioned bylocation of deep venous thrombosis? Ann Intern Med 1981;94 (4 pt 1): 439-44. doi: 10.7326/0003-4819-94-4-439.

  3. Agnelli G. Prevention of venous thromboembolism in surgicalpatients. Circulation. 2004; 110 (24 Suppl 1): IV4-12.doi: 10.1161/01.CIR.0000150639.98514.6c.

  4. Girard P, Decousus M, Laporte S, Buchmuller A, HerveP, Lamer C, et al. Diagnosis of pulmonary embolism inpatients with proximal deep vein thrombosis: specificityof symptoms and perfusion defects at baseline and duringanticoagulant therapy. Am J Respir Crit Care Med 2001; 164(6): 1033-7. doi: 10.1164/ajrccm.164.6.2101045.

  5. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'FallonWM, Melton LJ, 3rd. Trends in the incidence of deepvein thrombosis and pulmonary embolism: a 25-yearpopulation-based study. Arch Intern Med 1998; 158 (6):585-93. doi: 10.1001/archinte.158.6.585.

  6. Martinez C, Cohen AT, Bamber L, Rietbrock S. Epidemiologyof first and recurrent venous thromboembolism: apopulation-based cohort study in patients without activecancer. Thromb Haemost 2014; 112 (2): 255-63. doi:10.1160/TH13-09-0793.

  7. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D,Brecht JG, et al. Venous thromboembolism (VTE) in Europe.The number of VTE events and associated morbidity andmortality. Thromb Haemost 2007; 98 (4): 756-64. https://doi.org/10.1160/TH07-03-0212.

  8. Análisis de situación de salud (ASIS) Colombia, 2016.In:Demografía. DdEy, editor: Ministerio de salud y protecciónsocial; 2016: 46-50.

  9. Dentali F, Ageno W, Becattini C, Galli L, Gianni M, Riva N, et al.Prevalence and clinical history of incidental, asymptomaticpulmonary embolism: a meta-analysis. Thromb Res 2010;125 (6): 518-22. doi: 10.1016/j.thromres.2010.03.016.

  10. Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, KakkarAK, Deslandes B, et al. Venous thromboembolism risk andprophylaxis in the acute hospital care setting (ENDORSEstudy): a multinational cross-sectional study. Lancet 2008;371 (9610): 387-94. doi: 10.1016/S0140-6736(08)60202-0.

  11. Dennis RJ AJ, Restrepo HF, Hernández JI, Rivas E, SabogalJE. Es apropiada la profilaxis actual del tromboembolismovenoso en pacientes médicos? Evaluación de desenlacescolombianos en el Registro Internacional sobre PrevenciónMédica del TEV (IMPROVE). Acta Med Colomb 2009; 34:11-96.

  12. Dennis R dAM, Rodríguez MN, Salazar MS, Posada PS. Estudionacional sobre tromboembolismo venoso en poblaciónhospitalaria en Colombia. Diferencias entre ciudades yespecialidades. Acta Med Colomb 1996; 21 (2): 55-63.

  13. Guyatt GH, Akl EA, Crowther M, Gutterman DD, SchuunemannHJ, American College of Chest Physicians AntithromboticT, et al. Executive summary: Antithrombotic Therapyand Prevention of Thrombosis, 9th ed: American Collegeof Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest 2012; 141 (2 Suppl): 7S-47S. doi: 10.1378/chest.1412S3.

  14. Velásquez JC. Uso de tromboprofilaxis en el pacientehospitalizado en la Clínica del Country Un análisis dela adherencia a la guía institucional. Acta Med Colomb2010; 35: 8-14.

  15. Sáenz-Morales O. Estudio PETRO: evaluación de tromboprofilaxisy riesgo embólico en pacientes hospitalizados enuna institución de tercer nivel en Bogotá, Colombia. RevistaColombiana de Neumología 2017; 29 (1): 7-18.

  16. Diaztagle J. Tromboprofilaxis en el paciente médicohospitalizado por medicina interna Un estudio de cortetransversal. Acta Med Colomb 2015; 40: 227-33.

  17. Arias-Romero JJ, Rodríguez-Amaya RM, Naranjo-Junoy F.Uso de tromboprofilaxis en pacientes con patología médica.Rev Colomb Cardiol 2016; 23 (5): 375-82.

  18. Martinez-Montalvo C. Experiencia en el uso de tromboprofilaxisfarmacológica en un hospital colombiano de tercernivel. Acta Medica de Perú 2018; 32 (5): 108-15.

  19. Cardona-Ospina J. Tromboprofilaxis en pacientes hospitalizados,¿estamos haciendo lo correcto? Rev Méd Risaralda

  20. 2013; 19 (1): 41-9.20. Garay-Vargas D. Evaluación de la tromboprofilaxis yprevalencia de los factores de riesgo de enfermedadtromboembólica en los pacientes médico-quirúrgicoshospitalizados en el Hospital Militar Central en Bogotá.Bogotá: Universidad Militar; 2012.

  21. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B,Perlati M, et al. A risk assessment model for the identificationof hospitalized medical patients at risk for venousthromboembolism: the Padua Prediction Score. J ThrombHaemost 2010; 8 (11): 2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.

  22. Cabrera-Rayo A H-DE, Guzmán-Rosales G, Laguna-Hernández G, Pliego-Reyes C, Zendejas-Villanueva JL,Pedraza-Méndez H, Rosas-Solís MI, Rivera-Guevara ML,Ortega-Román D, Lozano-VillalbaFM, García-Méndez N,Hernández-Cid de León S, Mata-Ruiz B, RamírezMontelongoS, Avilés-Hernández R, Duque-Molina C. Tromboprofilaxisen pacientes médicos y quirúrgicos: resultados de unestudio multicéntrico realizado en hospitales de la Ciudadde México. Med Int Méx 2017; 33 (6): 746-53. https://doi.org/10.24245/mim.v33i6.1461.

  23. Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD,Soukonnikov B, et al. Electronic alerts to prevent venousthromboembolism among hospitalized patients. N Engl JMed 2005; 352 (10): 969-77. doi: 10.1056/NEJMoa041533.

  24. Beeler PE, Eschmann E, Schumacher A, Studt JD, Amann-Vesti B, Blaser J. Impact of electronic reminders on venousthromboprophylaxis after admissions and transfers. J AmMed Inform Assoc 2014; 21 (e2): e297-303. doi: 10.1136/amiajnl-2013-002225.

  25. Martin-Asenjo M, Martin-Guerra JM, Usategui-Martin I,Sanchez-Munoz LA. Areas of improvement in thromboprophylaxisof hospitalized medical patients. Rev Clin Esp2018; 218 (2): 111-3. DOI: 10.1016/j.rceng.2017.10.007.

  26. Yates M, Reddy M, Machumpurath B, Phelps G, HampsonSA. Modification of the National Inpatient Medication Chartimproves venous thromboembolism prophylaxis rates inhigh-risk medical patients. Intern Med J 2014; 44 (2): 190-4.doi: 10.1111/imj.12346.

  27. Hamieh T, Michota F. Educational interventions alone are notsufficient to change outcomes in venous thromboembolism.J Hosp Med 2009; 4 (2): 142-3. doi: 10.1002/jhm.405.




2020     |     www.medigraphic.com